Risedronate Mylan 35 mg Weekly film-coat. tabl.
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Sodium Risedronate 35 mg - Eq. Risedronic Acid 32,5 mg
Available from:
Viatris GX BV-SRL
ATC code:
M05BA07
Pharmaceutical form:
Film-coated tablet
Administration route:
Oral use
Therapeutic area:
Risedronic Acid
Product summary:
CTI Extended: 525875-04; 525875-03; 525875-02; 525875-06; 525875-08; 525875-01; 525875-07; 525875-05
Authorization status:
Commercialised: No
Authorization date:
2018-02-21
